Nicole Kelsey - Jul 1, 2024 Form 3 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Chief Legal/Compliance Officer
Signature
/s/ Nicole Kelsey
Stock symbol
RCEL
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
3
Date filed
7/3/2024, 01:26 PM
Previous filing
Sep 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RCEL Stock Options (Right to Buy) Jul 1, 2024 Common Stock 150K $7.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date of July 1, 2024.